| P504S/alpha-methylacyl-CoA racemase, HNF1beta and napsin A in morular metaplasia and clear cell carcinoma of the endometrium: An immunohistochemical analysis. | P504S/alpha-methylacyl-CoA racemase, HNF1β and napsin A in morular metaplasia and clear cell carcinoma of the endometrium: An immunohistochemical analysis.
Arciuolo D, Travaglino A, Raffone A, Santoro A, Inzani F, Piermattei A, Bui L, Scaglione G, D'Alessandris N, Valente M, Fulgione C, Guida M, Mollo A, Insabato L, Zannoni GF. | 08/13/2022 |
| A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa. | A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Gaydarov N, Martinelli-Kläy CP, Lombardi T. | 03/5/2022 |
| Napsin-A and AMACR are Superior to HNF-1beta in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract. | Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.
Pors J, Segura S, Cheng A, Ji JX, Tessier-Cloutier B, Cochrane D, Fix DJ, Park K, Gilks B, Hoang L., Free PMC Article | 08/7/2021 |
| Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma. | Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
Mohammed Salama ME., Free PMC Article | 08/7/2021 |
| Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors. | Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Sharifai N, Abro B, Chen JF, Zhao M, He H, Cao D. | 02/20/2021 |
| Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival. | Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival.
Pocha K, Mock A, Rapp C, Dettling S, Warta R, Geisenberger C, Jungk C, Martins LR, Grabe N, Reuss D, Debus J, von Deimling A, Abdollahi A, Unterberg A, Herold-Mende CC. | 02/6/2021 |
| Immunohistochemical expression of Napsin A in normal human fetal lungs at different gestational ages and in acquired and congenital pathological pulmonary conditions. | Immunohistochemical expression of Napsin A in normal human fetal lungs at different gestational ages and in acquired and congenital pathological pulmonary conditions.
Giordano G, Campanini N, Varotti E. | 10/10/2020 |
| Data indicate that lung napsin A aspartic peptidase (napsin A) in many mammals is a heterogeneous enzyme. | Pepstatin pull-down at high pH is a powerful tool for detection and analysis of napsin A.
Maurer A, Kalbacher H. | 07/4/2020 |
| Napsin A is of value in resolving diagnostic confusion between gastric-type adenocarcinoma (GAS) and clear cell carcinoma (CCC), whereas HNF1beta lacks specificity and its use in this setting is discouraged. | Expression of Markers of Müllerian Clear Cell Carcinoma in Primary Cervical and Vaginal Gastric-type Adenocarcinomas.
Talia KL, Wong RW, McCluggage WG. | 08/3/2019 |
| Raspberry bodies and hyaline globules with positive napsin A immunoexpression are useful features in diagnosing clear cell carcinoma. | Raspberry bodies and hyaline globules with positive napsin A immunoexpression are useful features in diagnosing clear cell carcinoma of the female genital tract in cytology samples.
Rekhi B, Deodhar K, Gulia S, Bajpai J. | 07/27/2019 |
| These data indicated that napsin A expression may inhibit TGFbetalinduced EMT and was negatively associated with EMTmediated erlotinib resistance, suggesting that napsin A expression may improve the sensitivity of lung cancer cells to EGFRTKI through the inhibition of EMT. | Napsin A is negatively associated with EMT‑mediated EGFR‑TKI resistance in lung cancer cells.
Zhou L, Lv X, Yang J, Zhu Y, Wang Z, Xu T. | 10/20/2018 |
| Although napsin A is infrequently expressed in endometrial carcinomas, positive results of napsin A immunostaining in endometrial neoplasms might support the diagnosis of clear cell carcinoma when the pathologic differential diagnosis includes other histologic subtypes | Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Al-Maghrabi JA, Butt NS, Anfinan N, Sait K, Sait H, Marzouki A, Khabaz MN. | 05/5/2018 |
| Immunohistochemical detection of thyroid transcription factor 1, Napsin A, and P40 fragment of TP63 can be used in the subclassification of non-small cell lung carcinomas. | Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
Sharma R, Wang Y, Chen L, Gurda GT, Geddes S, Gabrielson E, Askin F, Li QK. | 08/19/2017 |
| it may be useful to combine NAPA and TTF-1 for increased sensitivity in lung cancer diagnostics. There is no substantial difference between monoclonal and polyclonal p40 and between different NAPA clones, whereas there is a difference between the TTF-1 clones 8G7G3/1 and SPT24 | Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Tran L, Mattsson JS, Nodin B, Jönsson P, Planck M, Jirström K, Botling J, Micke P, Brunnström H. | 08/5/2017 |
| To the best of our knowledge, expression of monoclonal Napsin A in lymphomas has never been reported. ALK-DLBCL should be considered in the differential diagnosis when evaluating a Napsin A-positive tumor of poorly differentiated morphology and of unknown primary | Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Jain D, Mallick SR, Singh V, Singh G, Mathur SR, Sharma MC. | 06/3/2017 |
| It is important for pathologists to be aware that breast carcinomas with apocrine features can express napsin A. | Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features.
Vitkovski T, Chaudhary S, Sison C, Nasim M, Esposito MJ, Bhuiya T. | 04/15/2017 |
| High Napsin A expression is associated with adenocarcinoma in non-small cell lung carcinoma. | Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M, Hoang MP, Della Pelle P, Morales-Oyarvide V, Huynh TG, Mark EJ, Mino-Kenudson M. | 02/25/2017 |
| Napsin-A, and Desmocollin-3 were sensitive and specific markers for the diagnosis of AC and SCC, respectively. Both markers allowed classification of 54/60 cases into either AC or SCC. | The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
Ezzat Nel-S, Tahoun N. | 12/17/2016 |
| napsin A is aberrantly expressed in a subset of lymphomas | Aberrant expression of napsin A in a subset of malignant lymphomas.
Nam SJ, Kim S, Kim JE, Lim MS, Elenitoba-Johnson KS, Kim CW, Jeon YK. | 10/22/2016 |
| CK7, TTF-1 and napsin A are predominantly expressed in primary lung adenocarcinoma patients, with CDX-2 being inconsistently expressed. | CDX-2 Expression in Primary Lung Adenocarcinoma.
Cowan ML, Li QK, Illei PB. | 09/17/2016 |
| The immunocytochemical expressions of napsin A and p40 in imprint cytology seem to be of great utility for the accurate histological differentiation of lung cancers. | Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Kawai T, Tominaga S, Hiroi S, Kameda K, Ogata S, Nakashima H, Ozeki Y, Nakanishi K. | 07/16/2016 |
| Combining HNF-1beta and napsin A may distinguish clear cell carcinoma from high-grade serous carcinoma, endometrioid adenocarcinoma and metastatic Krukenberg tumors. | Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.
Li Q, Zeng X, Cheng X, Zhang J, Ji J, Wang J, Xiong K, Qi Q, Huang W., Free PMC Article | 06/11/2016 |
| napsin A is another sensitive and specific marker for distinguishing ovarian clear cell tumors (especially adenocarcinomas) from other ovarian tumors | Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Yamashita Y, Nagasaka T, Naiki-Ito A, Sato S, Suzuki S, Toyokuni S, Ito M, Takahashi S. | 04/2/2016 |
| Napsin A is expressed in a broad spectrum of renal neoplasms. | Immunoexpression of napsin A in renal neoplasms.
Zhu B, Rohan SM, Lin X., Free PMC Article | 02/6/2016 |
| Low expression levels of NAPSA is associated with lung adenocarcinoma. | The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
Ma Y, Fan M, Dai L, Kang X, Liu Y, Sun Y, Yan W, Liang Z, Xiong H, Chen K. | 01/30/2016 |